Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
Titel:
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
Auteur:
Reich, Kristian Thyssen, Jacob P Blauvelt, Andrew Eyerich, Kilian Soong, Weily Rice, Zakiya P Hong, H Chih-ho Katoh, Norito Valenzuela, Fernando DiBonaventura, Marco Bratt, Tamara A Zhang, Fan Clibborn, Claire Rojo, Ricardo Valdez, Hernan Kerkmann, Urs